Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
21.85
+0.36 (1.68%)
At close: Jun 9, 2025, 4:00 PM
21.90
+0.05 (0.23%)
After-hours: Jun 9, 2025, 7:43 PM EDT
Rigel Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for Rigel Pharmaceuticals stock ranges from a low of $23 to a high of $57. The average analyst price target of $36.4 forecasts a 66.59% increase in the stock price over the next year.
Price Target: $36.40 (+66.59%)
Analyst Consensus: Buy
* Price targets were last updated on May 7, 2025.
Analyst Ratings
The average analyst rating for Rigel Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $20 → $23 | Hold | Maintains | $20 → $23 | +5.26% | May 7, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $49 → $55 | Strong Buy | Maintains | $49 → $55 | +151.72% | Mar 6, 2025 |
| B. Riley Securities | B. Riley Securities | Hold Maintains $20 → $24 | Hold | Maintains | $20 → $24 | +9.84% | Mar 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $57 | Strong Buy | Reiterates | $57 | +160.87% | Mar 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $57 | Strong Buy | Reiterates | $57 | +160.87% | Jan 23, 2025 |
Financial Forecast
Revenue This Year
205.12M
from 179.28M
Increased by 14.41%
Revenue Next Year
237.88M
from 205.12M
Increased by 15.97%
EPS This Year
1.15
from 0.99
Increased by 15.74%
EPS Next Year
1.61
from 1.15
Increased by 40.43%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 217.1M | 273.5M | 294.0M | ||
| Avg | 205.1M | 237.9M | 268.5M | ||
| Low | 185.0M | 217.2M | 245.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.1% | 33.4% | 23.6% | ||
| Avg | 14.4% | 16.0% | 12.9% | ||
| Low | 3.2% | 5.9% | 3.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.30 | 2.92 | 1.51 | ||
| Avg | 1.15 | 1.61 | 1.47 | ||
| Low | 0.91 | 1.03 | 1.41 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 31.5% | 154.8% | -6.0% | ||
| Avg | 15.7% | 40.4% | -8.7% | ||
| Low | -7.9% | -10.2% | -12.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.